• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Studies on the bioavailability of glibenclamide].

作者信息

Rupp W, Christ O, Fülberth W

出版信息

Arzneimittelforschung. 1972 Feb;22(2):471-3.

PMID:4623702
Abstract
摘要

相似文献

1
[Studies on the bioavailability of glibenclamide].[格列本脲生物利用度的研究]
Arzneimittelforschung. 1972 Feb;22(2):471-3.
2
Comparison of the pharmacokinetics of glipizide and glibenclamide in man.格列吡嗪与人格列本脲的药代动力学比较。
Eur J Clin Pharmacol. 1975;8(1):63-9. doi: 10.1007/BF00616416.
3
Metabolism and kinetics of the hypoglycemic agent glipizide in man--comparison with glibenclamide.
J Clin Pharmacol New Drugs. 1973 Feb-Mar;13(2):68-75. doi: 10.1002/j.1552-4604.1973.tb00255.x.
4
[Potentiation of the hypoglycemic effect of sulfonylurea derivatives by drugs. II. Pharmacokinetics and metabolism of glibenclamide (HB 419) in presence of phenylbutazone].[药物对磺酰脲类衍生物降血糖作用的增强。II. 保泰松存在下格列本脲（HB 419）的药代动力学与代谢]
Eur J Clin Pharmacol. 1971 Dec;4(1):32-7. doi: 10.1007/BF00568896.
5
Metabolism of glipizide in the rat and dog and its tissue distribution in the mouse.
Arzneimittelforschung. 1973 Feb;23(2):242-7.
6
Pharmacokinetics of gliquidone, glibenclamide, gliclazide and glipizide in middle-aged and aged subjects.中年和老年受试者中格列喹酮、格列本脲、格列齐特和格列吡嗪的药代动力学
Res Commun Mol Pathol Pharmacol. 1999 Feb;103(2):211-22.
7
Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.格列本脲和格列吡嗪，第二代口服磺酰脲类降糖药。
Clin Pharm. 1984 Sep-Oct;3(5):473-85.
8
[Pharmacokinetics of glibornuride].
Arzneimittelforschung. 1972 Dec;22:Suppl 12A:2209.
9
Food intake and drug bioavailability.食物摄入与药物生物利用度。
Prog Clin Biol Res. 1981;77:747-56.
10
[Kinetics of glibenclamide in the dog].[格列本脲在犬体内的动力学]
Farmaco Prat. 1978 Jun;33(6):271-5.

引用本文的文献

1
Drugs acting on SUR1 to treat CNS ischemia and trauma.作用于SUR1的药物用于治疗中枢神经系统缺血和创伤。
Curr Opin Pharmacol. 2008 Feb;8(1):42-9. doi: 10.1016/j.coph.2007.10.004. Epub 2007 Nov 26.
2
Effect of genetic polymorphisms in cytochrome p450 (CYP) 2C9 and CYP2C8 on the pharmacokinetics of oral antidiabetic drugs: clinical relevance.细胞色素P450（CYP）2C9和CYP2C8基因多态性对口服抗糖尿病药物药代动力学的影响：临床相关性
Clin Pharmacokinet. 2005;44(12):1209-25. doi: 10.2165/00003088-200544120-00002.
3
Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.
磺酰脲类降糖药的临床药理学：第2部分。
Drugs. 1981 Oct;22(4):295-320. doi: 10.2165/00003495-198122040-00003.
4
Clinical pharmacokinetics of sulphonylurea hypoglycaemic drugs.磺酰脲类降糖药物的临床药代动力学
Clin Pharmacokinet. 1981 May-Jun;6(3):215-41. doi: 10.2165/00003088-198106030-00003.
5
Pharmacokinetics of intravenous glibenclamide investigated by a high performance liquid chromatographic assay.采用高效液相色谱法测定静脉注射格列本脲的药代动力学。
Diabetologia. 1982 Jul;23(1):37-40. doi: 10.1007/BF00257728.
6
Effect of pirprofen on glibenclamide kinetics and response.吡洛芬对格列本脲动力学及反应的影响。
Br J Clin Pharmacol. 1982 Jul;14(1):123-6. doi: 10.1111/j.1365-2125.1982.tb04949.x.
7
Pharmacokinetics and pharmacodynamics as well as metabolism following orally and intravenously administered C14-glipizide, a new antidiabetic.
Diabetologia. 1973 Sep:320-30. doi: 10.1007/BF01218442.
8
The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs.口服降糖药的药代动力学与药效学效应之间的关系。
Clin Pharmacokinet. 1987 Jun;12(6):379-401. doi: 10.2165/00003088-198712060-00001.
9
Highly potent and stereoselective effects of the benzoic acid derivative AZ-DF 265 on pancreatic beta-cells.苯甲酸衍生物AZ-DF 265对胰腺β细胞具有高效且立体选择性的作用。
Br J Pharmacol. 1988 Jan;93(1):61-8. doi: 10.1111/j.1476-5381.1988.tb11405.x.
10
Pharmacokinetic-pharmacodynamic relationships of oral hypoglycaemic agents. An update.口服降糖药的药代动力学-药效学关系。最新进展。
Clin Pharmacokinet. 1989 Feb;16(2):100-28. doi: 10.2165/00003088-198916020-00004.